Top Sell
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.54 | - | - |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.45 | €58.50 | 685.235% |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.12 | - | - |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| D.Western Therapeutics Institute Inc | 0 | 1 | 0 | 0 | €0.38 | - | - |
| Actinium Pharmaceuticals Inc. | 0 | 1 | 0 | 1 | €1.59 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.80 | - | - |
| Karyopharm Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.72 | €5.49 | 664.680% |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.21 | €10.66 | 781.132% |
| Indivior plc | 0 | 2 | 0 | 0 | €9.60 | €6.00 | -37.500% |
| Minerva Neurosciences Inc. | 0 | 11 | 0 | 2 | €2.36 | - | - |
| Alterity Therapeutics Ltd. ADR | 0 | 1 | 0 | 0 | €0.65 | - | - |
| Organovo Holdings Inc. | 0 | 10 | 0 | 2 | €0.48 | - | - |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.11 | €1.20 | 8.108% |
| Cellectar BioSciences Inc. | 4 | 4 | 0 | 0 | €1.91 | €14.75 | 672.398% |
| AEterna Zentaris Inc. | 2 | 21 | 0 | 1 | €1.87 | €8.51 | 355.096% |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.45 | - | - |
| Trevena Inc. | 2 | 23 | 0 | 2 | €0.15 | €6.48 | 4136.601% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.78 | €21.44 | 216.292% |
| Immuron | 0 | 1 | 0 | 0 | €2.12 | - | - |